Distribution Services · Medical Distributors · NSE: AAKAAR · data 2026-10-09
Aakaar Medical Technologies Limited
Health check: Strong (7.4/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹68
Market cap
₹94 cr
P/E
14.5
P/B
1.8
ROE
17.1%
ROCE
25.8%
Debt / equity
0.34
Dividend yield
0.00%
1-year return
-20.9%
52-week high
₹90
52-week low
₹46
Operating margin
15.0%
Growth
| Revenue (last 12 months) | ₹67 cr |
| Net profit (last 12 months) | ₹7 cr |
| Sales growth, 3 years (yearly) | 27.1% |
| Profit growth, 3 years (yearly) | 45.5% |
Similar companies
QMS Medical Allied Services Limited (QMSMEDI) · Vijaypd Ceutical Limited (VIJAYPD) · Balaxi Pharmaceuticals Limited (BALAXI) · Vivo Bio Tech Ltd. (VIVOBIOT) · Mono Pharmacare Limited (MONOPHARMA)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open AAKAAR in NSE Scanner →